Gilead Sciences as of Sept. 30, 2025
Portfolio Holdings for Gilead Sciences
Gilead Sciences holds 9 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Galapagos Nv Spon Adr (GLPG) | 32.3 | $579M | 17M | 34.64 | |
| Arcellx Common Stock (ACLX) | 30.8 | $552M | 6.7M | 82.10 | |
| Arcus Biosciences Incorporated (RCUS) | 23.9 | $427M | 31M | 13.60 | |
| Assembly Biosciences Com New (ASMB) | 6.4 | $115M | 4.5M | 25.60 | |
| Merus N V (MRUS) | 2.4 | $43M | 453k | 94.15 | |
| Tango Therapeutics (TNGX) | 2.3 | $41M | 4.9M | 8.40 | |
| Kyverna Therapeutics (KYTX) | 1.4 | $25M | 4.1M | 6.00 | |
| Xilio Therapeutics (XLO) | 0.4 | $7.7M | 9.1M | 0.84 | |
| Leap Therapeutics Com New (LPTX) | 0.1 | $2.4M | 5.3M | 0.45 |
